When IVF attempts keep failing, the next step should not automatically be another identical cycle or a long list of additional tests. The more useful approach is to review exactly where each cycle stopped progressing, identify patterns across the cycles, and choose a targeted response.
That response may involve changing the ovarian-stimulation plan, reviewing fertilization and embryo development, assessing the uterus, addressing male factors, planning a frozen embryo transfer, discussing genetic testing, considering donor eggs or sperm, obtaining a second opinion, or taking a break.
This guide is for individuals and couples dealing with repeated IVF failure who need a clearer framework for deciding what to do next. Those recovering from their first unsuccessful cycle may first find it useful to read about what to do after a single failed IVF cycle.
Infertility affects approximately one in six people of reproductive age worldwide, according to the World Health Organization. The causes may involve male factors, female factors, both partners or remain unexplained.
Repeated IVF failure is a broad description, not one single diagnosis. It can refer to repeated problems at different stages of treatment:
These patterns should not all be labelled “implantation failure.” They involve different biological stages and may require different investigations or treatment decisions.
No. Recurrent implantation failure specifically relates to unsuccessful implantation after embryo transfer. Repeated IVF failure is wider and may include poor ovarian response, fertilization failure, poor embryo development, unsuccessful transfer or pregnancy loss.
The European Society of Human Reproduction and Embryology notes that recurrent implantation failure does not have one universally consistent definition. It recommends assessing the patient’s individual expected chance of implantation rather than relying only on a fixed number of failed transfers.
This distinction matters. A patient whose embryos repeatedly stop developing needs a different review from someone who has transferred several suitable embryos without pregnancy.
The first major decision is not “Which treatment should we try next?” It is:
At which stage did progress repeatedly stop?
This pattern may include:
A specialist may review age, ovarian-reserve results, medication doses, stimulation duration, monitoring, trigger timing and previous responses.
AMH and antral follicle count can help estimate expected ovarian response, but they cannot determine the quality of an individual egg or guarantee whether pregnancy will occur.
This pattern may include:
Both egg and sperm factors may contribute. The laboratory should review egg maturity, sperm parameters, fertilization method and timing.
ICSI may be considered for selected fertilization problems, particularly where male-factor infertility or previous fertilization failure is relevant. In ICSI, one sperm is injected directly into an egg.
ICSI may help overcome certain fertilization barriers, but it does not correct every egg-quality, sperm-quality or embryo-development problem.
Some cycles produce fertilized eggs but few or no transferable embryos. The review should examine:
Embryo development can be affected by egg factors, sperm factors, chromosome abnormalities, laboratory variables or a combination of factors. One poor cycle does not always establish a permanent pattern, but repeated similar results deserve a detailed embryology review.
This pattern occurs when transferable embryos are available but pregnancy does not develop after transfer.
A review may consider:
Transvaginal ultrasound is generally part of fertility assessment. ESHRE advises renewed uterine evaluation when recurrent implantation failure is suspected, especially when new symptoms or ultrasound findings raise concern. Hysteroscopy may be considered when a uterine-cavity abnormality or intrauterine adhesion is suspected.
A positive pregnancy test followed by repeated miscarriage is not the same as failure to implant.
Possible discussions may include:
ESHRE’s recurrent-pregnancy-loss guidance covers evaluation after two or more pregnancy losses and emphasizes evidence-based, individualized care.
A new treatment decision should not be made only because the previous result was disappointing.
Allow enough time to:
A pause does not necessarily mean stopping treatment for months. It means avoiding a rushed decision before understanding what happened.
Ask for copies of:
The aim is to compare cycles objectively. Memory alone may not reveal whether the same stage failed repeatedly.
Use the records to place the case into one or more categories:
| Observed pattern | Main area to review | Possible decision direction |
|---|---|---|
| Repeatedly few eggs | Ovarian response and reserve | Modify stimulation, discuss realistic egg yield or donor eggs |
| Many immature eggs | Trigger timing and maturation | Review stimulation and trigger strategy |
| Low fertilization | Egg maturity, semen and method | Consider whether ICSI is indicated |
| Few blastocysts | Embryo-development pattern | Embryology review and targeted male or genetic discussion |
| Suitable embryos but no pregnancy | Uterus, transfer and embryo factors | Uterine review, transfer planning and selective PGT discussion |
| Repeated early losses | Pregnancy-loss pathway | Recurrent-loss assessment and genetic counselling |
| Different problem each cycle | Overall prognosis and process | Comprehensive second opinion and cumulative strategy |
This classification prevents every failed IVF cycle from being treated as though the uterus is automatically responsible.
Every proposed test should answer four questions:
A comprehensive fertility assessment may include ovarian-reserve testing, semen analysis, ultrasound, uterine assessment, hormone testing, hysteroscopy or genetic testing, depending on the person’s history and previous treatment results.
Testing should be selected because the history supports it—not simply because several treatments have failed.
The decision may be to:
A good decision is not necessarily the most technologically advanced option. It is the option whose expected benefit, limitations, emotional burden, cost and values make sense for the individual or couple.
No single investigation is appropriate for everyone.
This may include:
The most valuable information may come from the response to previous stimulation rather than repeating the same blood tests without changing the plan.
A current semen analysis may be reasonable when:
ESHRE’s recurrent-implantation-failure recommendations do not support routine sperm DNA-fragmentation or sperm FISH testing for every patient with suspected recurrent implantation failure because evidence and test standardization remain limited.
That does not mean such tests are never discussed. It means the clinician should explain the specific indication and how the result would alter management.
Depending on previous findings and symptoms, assessment may include:
Routine invasive investigation is not automatically needed after every failed transfer. The decision should be guided by previous imaging, symptoms and transfer history.
Targeted testing may include thyroid function, prolactin, glucose regulation or other investigations when the person’s symptoms, reproductive history or medical conditions justify them.
Repeating broad panels without a clinical question can increase cost and produce incidental findings that may not explain the IVF result.
Genetic counselling or testing may be considered when there is:
The type of genetic test must match the question being asked.
PGT-A may be considered in selected cases, but it is not a universal solution for failed IVF.
PGT-A screens embryo-biopsy samples for chromosome-number abnormalities. It does not improve the biological quality of an embryo, correct uterine conditions or guarantee implantation.
ESHRE states that PGT-A can be considered in recurrent implantation failure, while also noting that randomized trials have not consistently demonstrated improved live-birth outcomes in this group.
The American Society for Reproductive Medicine similarly reports that the value of PGT-A as a routine screening test for all IVF patients remains unclear and that study results are mixed.
A meaningful discussion should include:
Readers can review when preimplantation genetic testing may be appropriate and explore Slavica IVF’s PGT service.
Repeated failure can create pressure to “try everything.” However, more treatment does not always mean better treatment.
ESHRE does not recommend routine use of several immune tests and empirical interventions for recurrent implantation failure, including peripheral or uterine natural-killer-cell testing, intralipid infusions, intravenous immunoglobulin, G-CSF, intrauterine PRP and low-molecular-weight heparin solely to increase pregnancy or live-birth chances in recurrent implantation failure.
Commercial endometrial-receptivity tests are also not supported for routine use in all patients with recurrent implantation failure. ESHRE notes that evidence remains insufficient, although selected assessment of endometrial function may be considered in specific circumstances.
Before accepting an add-on, ask:
| Option | When it may fit | Important limitation |
|---|---|---|
| Repeat IVF with protocol changes | Previous cycle provided useful information and another retrieval remains reasonable | A changed protocol cannot eliminate age-related or biological uncertainty |
| Frozen embryo transfer | Suitable frozen embryos remain and the uterine plan can be optimized | It does not resolve embryo-related limitations |
| ICSI | Severe male factor or previous fertilization failure is relevant | It does not guarantee normal embryo development |
| Uterine treatment | A confirmed polyp, fibroid, adhesion or other cavity problem is present | Treatment should address a documented problem, not an assumed one |
| PGT-A | Selected age, embryo or miscarriage circumstances justify discussion | It adds cost and may leave no embryo recommended for transfer |
| Donor eggs | Repeated severe egg-factor problems, very low response or age-related concerns make own-egg treatment unlikely to be effective | Requires medical, emotional, ethical and legal counselling |
| Donor sperm | Severe sperm-factor problems cannot be adequately addressed through other approaches | Requires informed consent and family-building counselling |
| Second opinion | Records are unclear, explanations are inconsistent or the same unsuccessful plan is being repeated | The second clinic needs complete records to provide meaningful advice |
| Treatment pause | Physical, emotional, financial or relationship strain is high | Age and reproductive prognosis should still be discussed |
| Stop treatment | Burden outweighs the acceptable chance of benefit | This is a personal decision and should not be treated as failure |
The practical importance of this comparison is that the “next step” is not always another retrieval. It may be a better transfer plan, a targeted intervention, donor treatment, a second opinion or a deliberate pause.
Donor eggs may be discussed when repeated cycles show a persistent egg-related limitation, such as:
This decision should not be introduced as an automatic response to one poor cycle. It requires a realistic discussion of prognosis, treatment process, emotional readiness, donor screening, consent, costs and future family communication.
Changing clinics is not automatically necessary, but a second opinion can be useful when:
A second opinion is most valuable when the new IVF doctor can review the complete cycle record.
When evaluating an IVF clinic in Nepal, ask whether the team offers:
People who have experienced several unsuccessful cycles may benefit from a structured review rather than immediately repeating treatment. Slavica IVF and Research Center offers IVF, fertility assessment, ICSI, genetic testing and related infertility services in Sinamangal, Kathmandu. A consultation can be used to review previous reports and discuss which options are relevant to the specific pattern of failure.
Repeated IVF treatment can affect grief, anxiety, relationships, work, travel and finances. These effects should be included in decision-making rather than treated as separate from medical care.
Before another cycle, discuss:
Slavica IVF lists fertility counselling and psychological assessment among its services.
Needing time does not mean abandoning the goal. It may help the next decision become more deliberate and sustainable.
Bring the previous records and ask:
A useful consultation should end with a written or clearly explained plan—not simply “try again.”
A hypothetical 39-year-old patient has completed two retrievals. Both produced very few mature eggs and no blastocysts.
The next discussion might focus on previous stimulation response, ovarian reserve, trigger strategy, expected egg yield, whether another modified retrieval remains reasonable, and when donor eggs should be discussed. Extensive implantation testing would not address the main pattern because no embryo reached transfer.
A hypothetical patient has transferred several blastocysts but has never had a positive pregnancy test.
The review might prioritize embryo details, uterine-cavity assessment, endometrial preparation, progesterone timing, transfer notes and whether PGT-A is relevant. The specialist should also explain which proposed implantation tests are supported and which remain uncertain.
A hypothetical couple becomes pregnant after embryo transfer on more than one occasion, but each pregnancy ends early.
This pattern may require a recurrent-pregnancy-loss pathway rather than being described only as failed implantation. Genetic counselling, uterine evaluation and selected medical investigations may become more relevant.
Repeated IVF failure is not one diagnosis. The next step depends on whether the repeated problem involves ovarian response, egg maturity, fertilization, embryo development, transfer, implantation or pregnancy loss.
Before another treatment:
For an individualized review, patients can contact Slavica IVF and Research Center in Sinamangal, Kathmandu, and bring all previous IVF, laboratory, imaging and pregnancy records.
This article provides general educational information. It is not a diagnosis or a personalized treatment plan. IVF investigations and treatment choices depend on age, medical history, ovarian reserve, sperm findings, embryo development, uterine health, previous treatment and personal preferences. Consult a qualified fertility specialist before making treatment decisions.
Another attempt may be reasonable, but the decision should follow a complete review of both cycles. Your specialist should identify where each cycle stopped progressing, whether the same pattern appeared twice and what would change in another attempt. Repeating the same plan without a clear explanation may not be the most useful next step.
There is no single number that applies to everyone. Recurrent implantation failure has historically been described using numbers of unsuccessful transfers, but ESHRE recommends considering the person’s individual expected implantation chance, embryo characteristics, age and treatment history rather than relying only on a fixed threshold.
No. Implantation can be influenced by embryo factors, uterine conditions, transfer-related factors and patient-specific circumstances. A uterine review may be appropriate, but assuming that the uterus is responsible can lead to unnecessary tests or treatments. Embryo development and previous transfer information must also be reviewed.
PGT-A may be discussed when age, recurrent miscarriage, embryo history or repeated transfer results create a relevant chromosome-related question. It should not be presented as mandatory or guaranteed to improve success. The number of available embryos, cost, potential mosaic results and possibility of having no recommended embryo for transfer should be explained.
Donor eggs may offer another pathway when repeated treatment indicates a major egg-related limitation, such as severe poor response, no usable embryos, a significant genetic concern or an age-related prognosis. The decision requires medical counselling as well as discussion of emotional, ethical, practical and financial considerations.
A clinic change is not automatically necessary. A second opinion may be valuable when previous results were not clearly explained, records are unavailable, the same plan is being repeated without rationale or unsupported add-ons are being promoted. Bring complete stimulation, retrieval, fertilization, embryo, transfer and pregnancy records to the new consultation.
The appropriate timing depends on physical recovery, test results, medical treatment, emotional readiness and age-related considerations. Some people may be medically able to begin another plan after a menstrual cycle, while others need additional assessment or a longer pause. Follow medication and timing instructions from the treating fertility team.
